Vasodilation and Hypotension of CZ454, an Analogue of Lacidipine through Inhibiting Extracellular Calcium Influx

Abstract

The aim of this study was to evaluate the effects of an analogue of lacidipine, CZ454 in in vitro and in vivo. The isometric tension of Sprague-Dawley rat arterial ring segments was recorded by a myography system. Intracellular calcium of vascular smooth muscle was determined by the confocal laser microscopy. Blood pressure of spontaneously hypertensive rats was measured using a tail-cuff blood pressure system. The results showed that CZ454 (10^− 9–10^− 6 mol/L) relaxed the mesenteric artery contracted by high K⁺ concentration-dependently, which was not affected by removal of the endothelium. CZ454 treatment shifted the concentration-contractile curves induced by phenylephrine, U46619, KCl and CaCl₂ to the right with the decreased E _max. CZ454 was more potent in the coronary and basilar artery than in the mesenteric artery. CZ454 did not reduce phenylephrine-induced vasoconstriction; however, it did inhibit the contraction caused by addition of CaCl₂ and did not change caffeine-induced contraction in the mesenteric artery in Ca^2 +-free solution. CZ454 decreased the vasoconstriction induced by Bay K 8644 in the presence of 60 mmol/L K⁺. CZ454 1.0 mg/kg administered by gavage lowered the systolic pressure and diastolic pressure by 20% and 17%, respectively. It was concluded that CZ454 lowers blood pressure and relaxes arteries with higher potency in coronary and basilar artery and that the vasodilation may involve inhibition of calcium influx.

Key words

CZ454 - lacidipine - vasodilator - hypertension - calcium

• References

• 1 Triggle DJ. 1,4-dihydropyridines as calcium channel ligands and privileged structures. Cellular and Molecular Neurobiology 2003; 23: 293-303
• 2 Fleckenstein A. History of calcium antagonists. Circ Res 1983; 52: I3-16
• 3 Bellemann P, Ferry D, Lubbecke F et al. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzneimittelforschung 1981; 31: 2064-2067
• 4 Tanaka K, Gotoh F, Muramatsu F et al. Effects of nimodipine (Bay e 9736) on cerebral circulation in cats. Arzneimittelforschung 1980; 30: 1494-1497
• 5 Faulkner JK, McGibney D, Chasseaud LF et al. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol 1986; 22: 21-25
• 6 Micheli D, Collodel A, Semeraro C et al. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. J Cardiovasc Pharmacol 1990; 15: 666-675
• 7 Triggle DJ. Calcium channel antagonists: Clinical uses-past, present and future. Biochemical Pharmacology 2007; 74: 1-9
• 8 Ferrari R. Major differences among the three classes of calcium antagonists. European Heart Journal 1997; 18: A56-A70
• 9 Vertkin AL, Topolyansky AV. Lacidipine – A representative of a third generation calcium antagonists. Kardiologiya 2002; 42: 100-103
• 10 Leonetti G. Clinical position of lacidipine, a new dihydropyridine calcium antagonist, in the treatment of hypertension. J Cardiovasc Pharmacol 1991; 18 (Suppl. 11) S18-S21
• 11 Motomura S, Wu ZJ, Hashimoto K. Lacidipine, a new long-acting dihydropyridine calcium antagonist, has high vascular selectivity against all intracardiac variables. Heart and Vessels 1993; 8: 16-22
• 12 Dasgupta A, Jeyaseeli L, Dutta NK et al. Studies on the antimicrobial potential of the cardiovascular drug lacidipine. In Vivo 2007; 21: 847-850
• 13 Keles MS, Bayir Y, Suleyman H et al. Investigation of effects of Lacidipine, Ramipril and Valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats. Molecular and Cellular Biochemistry 2009; 328: 109-117
• 14 Zanchetti A, Hennig M, Baurecht H et al. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. Journal of Hypertension 2007; 25: 2463-2470
• 15 Heber ME, Broadhurst PA, Brigden GS et al. Effectiveness of the once-daily calcium antagonist, lacidipine, in controlling 24-hour ambulatory blood pressure. Am J Cardiol 1990; 66: 1228-1232
• 16 Guo ZJ, Zhou K, Cao YX et al. Synthesis and antihypertensive activity evaluation in spontaneously hypertensive rats of lacidipine analogues. Med Chem Res 2011;
• 17 Adner M, Cantera L, Ehlert F et al. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol 1996; 119: 1159-1166
• 18 Sun T, Liu R, Cao YX. Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms. Acta Pharmacol Sin 2011; 32: 1009-1018
• 19 Hashimoto T, Ohata H, Nobe K et al. A novel approach for the determination of contractile and calcium responses of the basilar artery employing real-time confocal laser microscopy. Journal of Pharmacological and Toxicological Methods 2007; 56: 79-86
• 20 Broekaert A, Godfraind T. A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline- and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries. Eur J Pharmacol 1979; 53: 281-288
• 21 Dai SP, Hall DD, Hell JW. Supramolecular Assemblies and Localized Regulation of Voltage-Gated Ion Channels. Physiological Reviews 2009; 89: 411-452
• 22 Takeuchi M, Watanabe J, Horiguchi S et al. Interaction between l-type Ca2 +  channels and sarcoplasmic reticulum in the regulation of vascular tone in isolated rat small arteries. Journal of Cardiovascular Pharmacology 2000; 36: 548-554
• 23 Kobayashi S, Gong MC, Somlyo AV et al. Ca2 +  channel blockers distinguish between G protein-coupled pharmacomechanical Ca2 +  release and Ca2 +  sensitization. Am J Physiol 1991; 260: C364-C370
• 24 Eckert RE, Karsten AJ, Utz J et al. Regulation of renal artery smooth muscle tone by alpha(1)-adrenoceptors: role of voltage-gated calcium channels and intracellular calcium stores. Urological Research 2000; 28: 122-127
• 25 Ford WR, Broadley KJ. Effects of adenosine receptor agonists on induction of contractions to phenylephrine of guinea-pig aorta mediated via intra- or extracellular calcium. General Pharmacology-the Vascular System 1999; 33: 143-150
• 26 Leijten PA, van Breemen C. The effects of caffeine on the noradrenaline-sensitive calcium store in rabbit aorta. J Physiol 1984; 357: 327-339
• 27 Schramm M, Thomas G, Towart R et al. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Arzneimittelforschung 1983; 33: 1268-1272
• 28 Hess P, Lansman JB, Tsien RW. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 1984; 311: 538-544
• 29 Triggle DJ, Janis RA. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2 +  channel. J Cardiovasc Pharmacol 1984; 6 (Suppl. 07) S949-S955
• 30 Alvarez SM, Miner AS, Browne BM et al. Failure of Bay K 8644 to induce RhoA kinase-dependent calcium sensitization in rabbit blood vessels. Br J Pharmacol 2010; 160: 1326-1337
• 31 Salaices M, Marin J, Sanchez-Ferrer CF et al. The effects of BAY-K-8644 on the contraction of cat middle cerebral and femoral arteries. Biochem Pharmacol 1985; 34: 3131-3135
• 32 Rico I, Alonso MJ, Salaices M et al. Pharmacological dissection of Ca2 +  channels in the rat aorta by Ca2 +  entry modulators. Pharmacology 1990; 40: 330-342
• 33 Barrus MT, Reviriego J, Marin J. Effect of Ca2 +  agonist Bay K 8644 in human placental arteries. Gen Pharmacol 1995; 26: 989-996
• 34 Bruschi G, Regolisti G, Borghetti A. Cellular calcium, vasoconstriction, hypertension. Ann Ital Med Int 1992; 7: 119S-123S